NCT03964727
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03964727
Title Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors (TROPiCS-03)
Acronym TROPiCS-03
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN | BEL | AUS


No variant requirements are available.